Sanofi Consumer Healthcare India Future Growth
Future criteria checks 5/6
Sanofi Consumer Healthcare India is forecast to grow earnings and revenue by 42.6% and 35.7% per annum respectively.
Key information
42.6%
Earnings growth rate
n/a
EPS growth rate
| Pharmaceuticals earnings growth | 17.9% |
| Revenue growth rate | 35.7% |
| Future return on equity | n/a |
| Analyst coverage | Low |
| Last updated | 18 Nov 2024 |
Recent future growth updates
No updates
Recent updates
Earnings and Revenue Growth Forecasts
| Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
|---|---|---|---|---|---|
| 12/31/2026 | 9,821 | 2,645 | 2,616 | N/A | 2 |
| 12/31/2025 | 8,787 | 2,298 | 2,298 | N/A | 2 |
| 12/31/2024 | 7,786 | 1,971 | 2,146 | N/A | 2 |
| 9/30/2024 | 2,314 | 393 | N/A | N/A | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: SANOFICONR's forecast earnings growth (42.6% per year) is above the savings rate (6.7%).
Earnings vs Market: SANOFICONR's earnings (42.6% per year) are forecast to grow faster than the Indian market (17.9% per year).
High Growth Earnings: SANOFICONR's earnings are expected to grow significantly over the next 3 years.
Revenue vs Market: SANOFICONR's revenue (35.7% per year) is forecast to grow faster than the Indian market (10.4% per year).
High Growth Revenue: SANOFICONR's revenue (35.7% per year) is forecast to grow faster than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: Insufficient data to determine if SANOFICONR's Return on Equity is forecast to be high in 3 years time